Weihua Yan
About Weihua Yan
Weihua Yan is a Senior Manager and Safety Physician at Bristol Myers Squibb in Tokyo, with over 20 years of experience in the medical and pharmaceutical fields across China and Japan.
Current Role at Bristol Myers Squibb
Weihua Yan currently serves as a Senior Manager, Safety Physician at Bristol Myers Squibb in Tokyo. In this role, he oversees safety assessments, ensuring patient safety in the development and distribution of pharmaceutical products. His extensive experience in pharmacovigilance and medical reviews enables him to effectively manage drug safety monitoring and evaluation processes.
Experience at Celgene
From 2018 to 2021, Weihua Yan worked at Celgene as Manager, Medical Reviewer in Tokyo. Here he was responsible for conducting comprehensive reviews of medical cases, assessing potential risks, and ensuring the compliance of medical practices with regulatory standards.
Role at Teva Takeda Pharma Ltd.
Between 2014 and 2018, Weihua served as Team Leader of the PhV group and Chairman of the Safety Assessment Committee at Teva Takeda Pharma Ltd. His responsibilities included leading the pharmacovigilance team and overseeing the safety assessment protocols, ensuring drug safety compliance, and conducting critical safety evaluations.
Early Career and Education
Weihua began his career as a Clinical Physician at The First People's Hospital of Yinchuan in China from 1998 to 2001. He holds a Bachelor in Medicine from NingXia Medical University, China, and a Ph.D. in Medicine specializing in Hematology from Tokyo Medical and Dental University. These educational credentials provided him a strong foundation in the medical field, which he has applied in various roles in his career.
Expertise in Pharmacovigilance
With over 20 years of experience in the medical and pharmaceutical fields, Weihua Yan has significant expertise in pharmacovigilance. He has worked as a Pharmaco-vigilance Medical Specialist at ASKLEP Inc. and CMIC-BS Co., LTD., contributing to drug safety evaluations, risk assessments, and compliance with regulatory standards.